Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ULTRAPROT-DHA
- Development stage
- Unknown
- Lead developer
- Sushma
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Administration
- Oral
01
Overview
ULTRAPROT-DHA is a protein powder dietary supplement enriched with docosahexaenoic acid (DHA). Developed and marketed by Sushma Biotech, it is formulated as a chocolate-flavored powder designed to support nutritional needs, muscle recovery, and cognitive health. DHA, an essential omega-3 fatty acid, supports brain development and cognitive function, while the protein component provides essential amino acids to support muscle growth, repair, and overall metabolic health.
- Brand names
- ULTRAPROT-DHA
- Other names
- Protein Powder With DHAUltraprot-DHA Protein powder
Beyond the preview
Go deeper on ULTRAPROT-DHA.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ULTRAPROT-DHA.